Ghorashi Seyyed Mojtaba, Salarifar Mojtaba, Poorhosseini Hamidreza, Sadeghian Saead, Jalali Arash, Aghajani Hassan, Haji-Zeinali Ali-Mohammad, Omidi Negar
Department of Cardiovascular Disease Research, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Department of Interventional Cardiology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Egypt Heart J. 2022 Mar 28;74(1):20. doi: 10.1186/s43044-022-00256-y.
There have been little data about the additive effects of coronary risk factors on mortality in diabetic patients presenting with non-ST-segment elevation myocardial infarction (NSTEMI). This study aimed to evaluate the predictors of mortality in diabetic patients presenting with NSTEMI. All patients admitted to Tehran Heart Center (THC) with a confirmed diagnosis of NSTEMI and a history of diabetes mellitus (DM) type 2 between September 2003 and April 2017 were included. Clinical characteristics and paraclinical data such as lipid profiles, creatinine, hemoglobin, and hemoglobin A1C (HbA1C) were evaluated in these patients to predict in-hospital mortality. The approach for model calibration was a logistic regression with the backward elimination method.
Of a total of 9158 patients with non-ST-segment elevation myocardial infarction, 3133 had diabetes mellitus type 2 and met our criteria to enter the final analysis. In the multivariable analysis, age, chronic obstructive pulmonary disease, and a severely reduced left ventricular ejection fraction (LVEF) significantly increased the rate of in-hospital mortality, whereas mildly and moderately reduced left ventricular ejection fraction did not increase the rate of mortality.
Age, chronic obstructive pulmonary disease (COPD), and severely reduced LVEF (< 30%) independently increased in-hospital mortality in our diabetic patients with a confirmed diagnosis of NSTEMI. Severely reduced LVEF had the strongest relationship with in-hospital mortality, whereas the mean HbA1C level and the type of DM management exerted no significant effect on in-hospital mortality.
关于冠心病危险因素对非ST段抬高型心肌梗死(NSTEMI)糖尿病患者死亡率的叠加影响,相关数据较少。本研究旨在评估NSTEMI糖尿病患者的死亡预测因素。纳入2003年9月至2017年4月期间在德黑兰心脏中心(THC)确诊为NSTEMI且有2型糖尿病(DM)病史的所有患者。对这些患者的临床特征和辅助检查数据,如血脂谱、肌酐、血红蛋白和糖化血红蛋白(HbA1C)进行评估,以预测住院死亡率。模型校准方法采用向后逐步回归的逻辑回归。
在总共9158例非ST段抬高型心肌梗死患者中,3133例患有2型糖尿病并符合进入最终分析的标准。在多变量分析中,年龄、慢性阻塞性肺疾病和左心室射血分数(LVEF)严重降低显著增加了住院死亡率,而左心室射血分数轻度和中度降低并未增加死亡率。
在我们确诊为NSTEMI的糖尿病患者中,年龄、慢性阻塞性肺疾病(COPD)和LVEF严重降低(<30%)独立增加了住院死亡率。LVEF严重降低与住院死亡率的关系最为密切,而平均HbA1C水平和DM管理类型对住院死亡率无显著影响。